Entity
Description
  • Value proposition

    Curing blindness with regenerative cell therapies.

    StemSight develops off-the-shelf regenerative cell therapies for corneal blindness. Our expertise is in the combination of iPS-derived cells with functional biomaterials - for FASTER tissue regeneration, SAFER cell therapies and EASIER cell delivery.

  • StemSight | Curing Blindness With Stem Cells | Finland

    StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.

  • https://www.stemsight.fi/
Corporate interactions
Corporate TypeTweets Articles
Paris Biotech Santé
Paris Biotech Santé
Startup accelerator & VC, Civic and Social Organizations
Paris Biotech Santé
Startup accelerator & VC, Civic and Social Organizations
Other

31 Oct 2024


Similar entities
Loading...
Loading...
Social network dynamics